TRIAZINE DERIVATIVES FOR USE IN A CICATRISING TREATMENT
申请人:POXEL SAS
公开号:EP1971329B1
公开(公告)日:2017-10-11
PROCESS FOR THE SYNTHESIS OF 3,6-DIHYDRO-1,3,5-TRIAZINE DERIVATIVES
申请人:POXEL SAS
公开号:EP2300444A2
公开(公告)日:2011-03-30
Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
申请人:Moinet Gerard
公开号:US20080108619A1
公开(公告)日:2008-05-08
The invention relates to the compounds of general formula (I):
in which R1, R2, R3, R4, R5 and R6 are as defined in Claim
1.
These compounds can be used in the treatment of pathological conditions associated with the insulin-resistance syndrome.
COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS
申请人:Moinet Gérard
公开号:US20100158999A1
公开(公告)日:2010-06-24
The present patent application relates to combinations of a triazine derivative with an HMG-CoA reductase inhibitor.
COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS
申请人:Moinet Gérard
公开号:US20100159005A1
公开(公告)日:2010-06-24
The present patent application relates to combinations of triazine derivatives and of PPARα agonists.